Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Palatin Technologies Inc (PTNT)

Palatin Technologies Inc (PTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of Melanocortin-Based Therapies for Obesity PR Newswire - Thu Nov 6, 2025

PRINCETON, N.J. , Nov. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity...

PTN : 22.40 (+1.50%)
PTNT : 8.5300 (-15.12%)
Palatin Technologies Announces Pricing of Upsized $15.8 Million Public Offering PR Newswire - Thu Nov 6, 2025

PRINCETON, N.J. , Nov. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT) ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules...

PTNT : 8.5300 (-15.12%)
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim PR Newswire - Mon Sep 22, 2025

PRINCETON, N.J. , Sept. 22, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company advancing medicines that modulate the melanocortin receptor system,...

PTNT : 8.5300 (-15.12%)
Palatin Announces 1-for-50 Reverse Stock Split PR Newswire - Fri Aug 8, 2025

PRINCETON, N.J. , Aug. 8, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), today announced a reverse stock split ("Reverse Stock Split") of its shares at a ratio of 1-for-50....

PTN : 22.40 (+1.50%)
PTNT : 8.5300 (-15.12%)
Why This French Biotech Stock Just Soared 586% in One Day wealthyventurecapitalist.com - Thu Jul 24, 2025

Shares of Abivax SA (NASDAQ: ABVX) went parabolic on Wednesday, skyrocketing 586% to close at $68.60 after the French biotech firm announced overwhelmingly positive Phase 3 data for its lead drug candidate,...

NDAQ : 87.67 (-0.13%)
PTN : 22.40 (+1.50%)
ABVX : 113.78 (-1.04%)
PTNT : 8.5300 (-15.12%)

Barchart Exclusives

Can Ethereum Make a Giant Comeback? Here’s the Bull Case. Barchart - 58 minutes ago
Bitcoin often hogs the spotlight, but the charts are indicating that a comeback could be in the cards for Ethereum. Here's what to know. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.